# Byers Capital

Investor in San Francisco, California

## About Byers Capital

Byers Capital is a family office with a focus on early-stage technology investing. We're building and investing in tech and biotech companies.

Announced investments include:

▪ Neuralink (Series B) ▪ NewLimit (Cofounded) ▪ Culdesac (Series A) ▪ Vial (Series A) ▪ Benchling (Growth) ▪ Freenome (Growth) ▪ Grail (Series A)

Byers Capital was founded in 2021 by Blake Byers and is based in San Francisco, CA.

## People

- **Blake Byers**, Founder & Investor

## Key Facts

- **Location:** San Francisco, California
- **Investor Type:** Venture Capital
- **Founded:** 2021

## Investment Industries

- Biotech
- Technology/Web/App

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/byers-capital
- More investors: [Biotech Investors in California](https://askforfunding.com/site/angel-investors/california/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
